John R Stuelpnagel sold $1.2M of TXG stock

John R Stuelpnagel, Dir of 10x Genomics, Inc. (TXG), sold 20,000 shares of TXG stock worth $1.2M, per an SEC Form 4 filed Sep 8, 2026.

It was an open-market sale.

The trade happened on Sep 3, 2026, 5 days before it was made public.

TXG has moved -6.5% since the trade date, from $63.22 to $59.10 (Nov 12, 2026 close).